MSK Commack is a clinical research site located in Commack, New York, United States 11725.
Crixeo Clinical Trials Trust Score: 21/100 (FAILING). This profile has not yet been claimed by the site owner.
MSK Commack has participated in 20 clinical trials with 14 currently active.
Therapeutic areas: Muscle-invasive Urothelial Carcinoma, Multiple Myeloma, Colorectal Neoplasms.
Sponsors: Hoffmann-La Roche, Pfizer, Seagen, a wholly owned subsidiary of Pfizer.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in New York · View every site in Commack
Trust Score: 21/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
MSK Commack has a Crixeo Trust Score of 21/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
MSK Commack has 20 clinical trials on record, with 14 currently active. Their work covers Muscle-invasive Urothelial Carcinoma, Multiple Myeloma, Colorectal Neoplasms.
MSK Commack has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.